The fund invests substantially all of its assets in the equity securities of non-U.S. based companies. It typically invests in common stocks. The fund does not choose its portfolio companies based on a reference to market capitalization. Rather, the focus of the it is on the revenue produced by the issuer of the securities. The fund typically holds a portfolio of between 40 to 70 securities which the Advisor believes have the potential for growth.
01 5月 2026現在、最大の保有資産はASML Holding NV, Givaudan SA, Cochlear Ltd, Novonesis (Novozymes) B, AJ Bell PLC, Descartes Systems Group Inc/Thを含みます。BCIIX ファンドの保有資産の完全なリストを確認してください。
BCIIX ファンドの保有資産は何ですか?
BCIIX ファンドは9の保有資産で構成されており、ASML Holding NV, Givaudan SA, Cochlear Ltdなどが含まれます。BCIIX ファンドの保有資産の完全なリストを確認してください。